Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q1 2022 vs. Q4 2021
How the institutions holding Cidara Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 53 | 44 | −9 |
| Shares | 31.1M | 30.3M | −780.2K (−2.5%) |
| Value | $39.5M | $25.2M | −$14.2M (−36.1%) |
New holders (4)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monashee Investment Management LLC | 369,099 | $307.0K | 0.09% |
| Shufro Rose & Co LLC | 10,413 | $9.00K | 0.00% |
| Stratos Wealth Partners, LTD. | 10,489 | $9.00K | 0.00% |
| Schonfeld Strategic Advisors LLC | 10,900 | $9.00K | 0.00% |
Sold out (13)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Laurion Capital Management LP | 198,635 | $252.0K |
| Marshall Wace, LLP | 146,408 | $185.0K |
| Citadel Advisors LLC | 126,185 | $161.0K |
| Cubist Systematic Strategies, LLC | 118,040 | $150.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 88,097 | $112.0K |
| XTX Topco Ltd | 39,446 | $50.0K |
| Susquehanna International Group, LLP | 22,236 | $28.0K |
| Kestra Advisory Services, LLC | 17,000 | $22.0K |
| Cetera Investment Advisers | 12,000 | $15.0K |
| ExodusPoint Capital Management, LP | 11,537 | $15.0K |
| Optiver Holding B.V. | 5,090 | $11.0K |
| Tyler-Stone Wealth Management | 750 | $1.00K |
| Castleview Partners, LLC | 6,986 | – |